Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy

Strahlentherapie und Onkologie

Volumn 187, Issue 9, 2011, Pages 555-560

  Kreppel, Matthias ^a,b   Drebber, Uta ^a,b   Eich, Hans Theodor ^a,b   Dreiseidler, Timo ^a,b   Zöller, Joachim E ^a,b   Müller, Rolf Peter ^a,b   Scheer, Martin ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases   (Germany)

Author keywords

Adjuvant radiochemotherapy; Carboplatin; Oral cancer; Prognosis

Indexed keywords

CARBOPLATIN;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS; MOUTH CARCINOMA; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UNIVARIATE ANALYSIS;

AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NECK DISSECTION; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 80755175837     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2245-8     Document Type: Article

References (51)

1. Adelstein D, Lavertu P, Saxton P, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000;58:876-83. (Pubitemid 30091108)
2. Bachaud M, Cohen-Jonathan E, Alzieu C, et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma. Int J Radiat Oncol Biol Phys 1996;36:999-1004. (Pubitemid 27014483)
3. Balermpas P, Hambek M, Seitz O, et al. Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck. Strahlenther Onkol 2009;185:775-81.
4. Berger B, Belka C, Weinmann M, et al. Reirradiation with alternating docetaxelbased chemotherapy for recurrent head and neck squamous cell carcinoma. Strahlenther Onkol 2010;86:2082-9.
5. Bernier J. Current state-of-the-art for concurrent chemoradiation. Semin Radiat Oncol 2009;19:3-10.
6. Bernier J, Cooper J. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence? Oncologist 2005;10:215-24. (Pubitemid 40463159)
7. Bernier J, Cooper J, Pajak T, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (2931) and RTOG (9501). Head Neck 2005;27:843-50. (Pubitemid 41395696)
8. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-52. (Pubitemid 38580197)
9. Bölke E, Gerber P, Lammering G, et al. Development and management of severe cutaneous side effects in head-and-neck-cancer patients during concurrent radiotherapy and cetuximab. Strahlenther Onkol 2008;184:105-10. (Pubitemid 351231657)
10. Bonner J, Harari P, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-78. (Pubitemid 43209104)
11. Bonner J, Harari P, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010;11:21-8.
12. Bourhis J, Overgaard J, Audry H, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006;368:843-54. (Pubitemid 44292807)
13. Brockstein B, Vokes EE. Concurrent chemoradiotherapy for head and neck cancer. Semin Oncol 2004;31:786-93. (Pubitemid 39602684)
14. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-6. (Pubitemid 30019568)
15. Cooper J, Pajak T, Forastiere A, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44.
16. Cox D. Regression modell and life-tables. J R Stat Soc 1972;34:187-220.
17. Dinshaw K, Agarwal J, Laskar S, et al. Head and neck squamous cell carcinoma: the role of post-operative adjuvant radiotherapy. J Surg Oncol 2005;91:48-55. (Pubitemid 40967380)
18. Driemel O, Ettl T, Kölbl O, et al. Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy. Strahlenther Onkol 2009;185:296-302.
19. Eckhardt A, Sinikovic B, Hofele C, et al. Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial. Oncology 2007;73:198-203. (Pubitemid 351630050)
20. Eckhardt A, Wildfang I, Karstens JH. Simultaneous radiochemotherapy with taxol/carboplatin in advanced operable head-neck tumors. Preliminary results. Strahlenther Onkol 1999;175:11-3.
21. Eder-Czembirek C, Erovic B, Czembirek C, et al. Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines. Strahlenther Onkol 2010;186:143-8.
22. Eich HT, Löschke M, Scheer M, et al. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients. Strahlenther Onkol 2008;184:23-9.
23. Eisenberger M, Hornedo J, Silva H, et al. Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 1986;4:1506-9. (Pubitemid 17183575)
24. Fan K, Lin C, Kang C, et al. Combined-modality treatment for advanced oral tongue squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2007;67:453-61. (Pubitemid 46108300)
25. Forastiere A, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: A Southwest Oncology Group Study. J Clin Oncol 1992;10:1245-51.
26. Freier K, Engel M, Lindel K, et al. Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients. Oral Oncol 2008;44:116-23. (Pubitemid 351179655)
27. Gil Z, Fliss D. Contemporary management of head and neck cancers. Isr Med Assoc J 2009;11:296-300.
28. Giralt JL, Gonzalez J, del Campo JM, et al. Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer 2000;89:939-45.
29. Hinerman R, Mendenhall W, Morris C, et al. Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 2004;26:984-4.
30. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457-81.
31. Kessler P, Grabenbauer G, Leher A, et al. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg 2008;46:1-5. (Pubitemid 350266150)
32. Kessler P, Grabenbauer G, Leher A, et al. Five year survival of patients with primary oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study. Strahlenther Onkol 2007;183:184-9. (Pubitemid 46570755)
33. Klug C, Berzaczy D, Voracek M, et al. Preoperative radiochemotherapy in the treatment of advanced oral cancer: outcome of 276 patients. J Craniomaxillofac Surg 2009;37:344-7.
34. Kovacs AF, Mose S, Böttcher HD, Bitter K. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer. Strahlenther Onkol 2005;181:26-34. (Pubitemid 40174983)
35. Kreppel M, Eich HT, Kübler AC, et al. Prognostic Value of the 6th Edition of the UICC's TNM Classification and Stage Grouping for Oral Cancer. J Surg Oncol 2010;102:443-9.
36. Kreppel M, Scheer M, Drebber U, et al. Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations. Virchows Archiv 2010;456:473-82.
37. Lavaf A, Genden E, Cesaretti J, et al. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Cancer 2008;112:535-43. (Pubitemid 351186195)
38. Liao CT, Chang JT, Wang HM, et al. Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and perineural invasion? Int J Radiat Oncol Biol Phys 2008;71:371-6. (Pubitemid 351636193)
39. Mohr C, Bohndorf W, Carstens J, et al. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric randomized DÖSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up). Int J Oral Maxillofac Surg 1994;23:140-8.
40. Patel S, Shah J. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 2005;55:242-58. (Pubitemid 41271230)
41. Posner M. Evolving strategies for combined-modality therapy for locally advanced head and neck cancer. Oncologist 2007;12:967-74. (Pubitemid 47359139)
42. Rutkowski T, Wygoda A, Hutnik M, et al. Intraoperative radiotherapy (IORT) with low-energy photons as a boost in patients with early-stage oral cancer with the indications for postoperative radiotherapy. Strahlenther Onkol 2010;186:496-501.
43. Schrijvers D, Vermorken J. Role of taxoids in head and neck cancer. Oncologist 2000;5:199-208. (Pubitemid 30429939)
44. Shah N, Trivedi T, Tankshali R, et al. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck 2009;31:1544-56.
45. Shaw J, Lowe D, Woolgar J, et al. Extracapsular spread in oral squamous cell carcinoma. Head Neck 2010;32:714-22.
46. Soo K, Tan E, Wee J, et al. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 2005;93:279-86. (Pubitemid 43080029)
47. Steinmann D, Cerny B, Karstens J, et al. Chemoradiotherapy with weekly cisplatin 40 mg/m2 in 103 head-neck cancer patients. Strahlenther Onkol 2010;185:682-8.
48. Tribius S, Kronemann S, Kilic Y, et al. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. Strahlenther Onkol 2009;185:675-81.
49. Wolff H, Bosch J, Jung K, et al. High-grade acute organ toxicity as positive prognostic factor in primary radio (chemo) therapy for locally advanced, inoperable head and neck cancer. Strahlenther Onkol 2010;186:262-8.
50. Woolgar J, Rogers S, Lowe D, et al. Cervical lymph node metastasis in oral cancer: the importance of even microscopic spread. Oral Oncol 2003;39:130-7. (Pubitemid 36050917)
51. Yuan P, Temam S, El-Naggar A, et al. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 2006;107:563-9. (Pubitemid 44107217)